Jonathan Rubin
Chief Tech/Sci/R&D Officer presso SUPERNUS PHARMACEUTICALS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Jonathan Rubin's current job is Senior VP-R&D, Chief Medical Officer at Supernus Pharmaceuticals, Inc. Dr. Rubin's former jobs include being a Medical Director at Shire Development LLC, Chief Medical Officer at Alcobra Ltd.
from 2013 to 2017, and Chief Medical Officer at Atentiv, Inc. from 2018 to 2020.
Dr. Rubin's education includes an undergraduate degree from Yale University, an MBA from Columbia Business School, and a doctorate from The University of Connecticut School of Medicine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ASHTROM GROUP LTD.
0.14% | 29/06/2023 | 144 849 ( 0.14% ) | 2 M $ | 31/03/2024 |
23/02/2024 | 4 641 ( 0.01% ) | 158 305 $ | 31/03/2024 |
Posizioni attive di Jonathan Rubin
Società | Posizione | Inizio |
---|---|---|
SUPERNUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Precedenti posizioni note di Jonathan Rubin
Società | Posizione | Fine |
---|---|---|
Atentiv LLC
Atentiv LLC Packaged SoftwareTechnology Services Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/02/2020 |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Chief Tech/Sci/R&D Officer | 01/09/2017 |
Shire Development LLC | Chief Tech/Sci/R&D Officer | - |
Formazione di Jonathan Rubin
Yale University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
The University of Connecticut School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
Shire Development LLC | |
Atentiv LLC
Atentiv LLC Packaged SoftwareTechnology Services Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA. | Technology Services |
- Borsa valori
- Insiders
- Jonathan Rubin